Intragel Expands Compassionate Use Program in Medias Klinikum to New Cancer Indications
We at Intragel are proud to expand our compassionate use program in @Medias Klinikum, Germany, where we’re making a significant impact on patients facing unique challenges in head and neck cancer and now in other cancer indications.
We’re not only providing hope to those who have exhausted traditional therapeutic options or are unable to undergo surgery, but also offering new safer and more efficacious routes.
We are very proud to share an inspiring story from a patient with foot sarcoma whose tumor resisted chemotherapy and presented treatment complications due to unclear tumor boundaries.
Using our Intragel technology that offers direct simple tumor injections, weeks of impact, and minimal side effects, the tumor is now responding with the patient having no severe side effects and he has already returned home!